Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing intensive cytotoxic…

Overview of attention for article published in Mycoses, January 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 4 X users

f1000: 1 research highlight platform

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Research highlights Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 46,057 followers.

RT @GermHunterMD: Mycoses: Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with AML or high…

03 Feb 2018

Reply Repost Favourite

RT @GermHunterMD: Mycoses: Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with AML or high…

19 Jan 2018

Reply Repost Favourite

RT @GermHunterMD: Mycoses: Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with AML or high…

18 Jan 2018

Reply Repost Favourite

Mycoses: Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with AML or high-risk MDS undergoing intensive cytotoxic chemotherapy: A real-world comparison https://t.co/gkgk2jRH5e

10 Jan 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.